Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

The role of serum calprotectin (S100A8/A9) in rheumatic diseases

Serum calprotectin plays a critical role in the pathogenesis of rheumatoid arthritis (RA), as it triggers chemotaxis, phagocyte migration, and modulation of neutrophils and macrophages. Calprotectin has been found to correlate with disease activity, and may add additional information to that provided by conventional biomarkers such as CRP. 

This webinar provides an overview of the many options for use of serum calprotectin in adult and pediatric patients suffering from autoinflammatory diseases such as rheumatoid arthritis, Still’s disease, vasculitis, and juvenile idiopathic arthritis (JIA).

2024-11-07
Prof. Dr. Marija Jeluŝić, Professor of paediatrics and vice-chair of the Department of Paediatrics at the University of Zagreb

Prof. Dr. Marija Jeluŝić, Croatia
Professor of paediatrics and vice-chair of the Department of Paediatrics at the University of Zagreb